Novo Nordisk (NYSE: NVO) is the maker of both blockbuster drugs, which have been a lucrative source of growth for the company. While this is all good news for Novo Nordisk, the company has yet to ...

Read more: The biggest loser of Trump’s trade war is the American consumer Here are stocks to watch today ... Shares of Novo Nordisk (NVO) climbed 3.5% after the company announced plans to ...

Based on the one-year price targets offered by 26 analysts, the average target price for Novo Nordisk AS (OCSE:NOVO B) is $838.77 with a high estimate of $1,150.00 and a low estimate of $515.00.

↗️Starbucks (SBUX): The coffee chain's stock ticked up from a two-month low clocked Friday when its union announced a five-day walkout across multiple cities, saying contract talks had hit an ...

Novo Nordisk shares rallied on Tuesday as a maker of a weight-loss drug alternative confirmed it won’t be selling it for much longer. Hims & Hers Health Inc.’s stock plunged last week when the ...

Every race car driver has sponsors. But not every driver depends on its car sponsor the way Charlie Kimball does: He has Type 1 diabetes and uses Novo Nordisk ($NVO ...

Clarivate’s Drugs to Watch in 2025 report (PDF) predicts that Novo’s new once-weekly insulin Awiqli will pick up $4.7 billion in sales by 2030, making it one of the hottest launches of the year.